Raia Drogasil (BSP:RADL3) Owner Earnings per Share (TTM): 0.66 (As of Jun. 2026) — 99% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
90 GF Score
Price R$17.53
GF Value R$27.32
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Raia Drogasil Owner Earnings per Share (TTM)?

Raia Drogasil BSP:RADL3 -4.21% 90 Owner Earnings per Share (TTM) is 0.66 as of Jun. 2026, which is 99% below its 10-year median of 65.44. GuruFocus rates BSP:RADL3 with a GF Score™ of 90/100 and a GF Value™ of R$27.32 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 300 Healthcare Providers & Services companies, Raia Drogasil ranks worse than 65.67% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Raia Drogasil's Owner Earnings per Share (TTM) ended in Jun. 2026 was R$0.66. It's Price-to-Owner-Earnings ratio for today is 26.56.


The historical rank and industry rank for Raia Drogasil's Owner Earnings per Share (TTM) or its related term are showing as below:

BSP:RADL3' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.92   Med: 65.44   Max: 751.63
Current: 26.56


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Raia Drogasil was 751.63. The lowest was 20.92. And the median was 65.44.


BSP:RADL3's Price-to-Owner-Earnings is ranked worse than
65.67% of 300 companies
in the Healthcare Providers & Services industry
Industry Median: 17.905 vs BSP:RADL3: 26.56

Raia Drogasil's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was R$0.25. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was R$0.81. It's PE Ratio (TTM) ratio for today is 21.62.

Raia Drogasil's EPS without NRI for the three months ended in Jun. 2026 was R$0.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was R$0.78. It's PE Ratio without NRI ratio for today is 22.39.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Raia Drogasil Owner Earnings per Share (TTM) Related Terms


Raia Drogasil Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Owner Earnings per Share (TTM) Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.11 -0.13 0.66 0.39

Raia Drogasil Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.79 0.39 0.41 0.66

Raia Drogasil Owner Earnings per Share (TTM) Competitor Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil Price-to-Owner-Earnings vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Price-to-Owner-Earnings falls into.


BSP:RADL3
90GF Score
Raia Drogasil SA BSP:RADL3
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Raia Drogasil's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 1,342
Depreciation, Depletion and Amortization 1,138
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 976
Change In Working Capital -398
Shares Outstanding (Diluted Average) 1,676

1. Start with "Net Income" from income statement. Raia Drogasil's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was R$1,342 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Raia Drogasil's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2026 was R$1,138 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Raia Drogasil's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2026 was R$0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = R$976 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Raia Drogasil's 5-Year Average Maintenance Capital Expenditure = R$976 Mil

5. "Change In Working Capital" is from cashflow statement. Raia Drogasil's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2026 was R$-398 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Raia Drogasil's Shares Outstanding (Diluted Average) for the months ended in Jun. 2026 was 1675.772 Mil.

Raia Drogasil's Onwer Earnings Per Share for Jun. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 1342.386 +1138.294+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-976.34481869548+-398.417)/1675.772
=0.66

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=17.53/0.66
=26.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 0.66 mean?
Raia Drogasil (BSP:RADL3) has a Owner Earnings per Share (TTM) of 0.66 as of Jun. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Raia Drogasil. This is 99% below median its historical median of 65.44. Over the past decade, Raia Drogasil's Owner Earnings per Share (TTM) has ranged from 20.92 to 751.63. According to the industry distribution chart, Raia Drogasil ranks #197 out of 300 companies in the Healthcare Providers & Services industry, placing it in the top 65.7%.
Is Raia Drogasil's Owner Earnings per Share (TTM) too high?
Raia Drogasil's current Owner Earnings per Share (TTM) of 0.66 is 99% below median its 10-year median of 65.44. Over the past 10 years, this metric has ranged from a low of 20.92 to a high of 751.63. The Healthcare Providers & Services industry median Owner Earnings per Share (TTM) is 17.91. Raia Drogasil's value of 0.66 is 96.3% below this industry median. Based on the distribution chart, Raia Drogasil ranks #197 out of 300 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Raia Drogasil has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Owner Earnings per Share (TTM) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Raia Drogasil ranks #197 out of 300 companies for Owner Earnings per Share (TTM). This places Raia Drogasil in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 17.91. Raia Drogasil's value of 0.66 is 96.3% below this benchmark. Historically, Raia Drogasil's own Owner Earnings per Share (TTM) has ranged from 20.92 to 751.63 over the past decade. While the company's 10-year median is 65.44 vs. the industry median of 17.91, Raia Drogasil has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Healthcare Providers & Services company?
The median Owner Earnings per Share (TTM) among Healthcare Providers & Services companies is 17.91, based on 300 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raia Drogasil's current Owner Earnings per Share (TTM) of 0.66 is 96.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Raia Drogasil. For the Healthcare Providers & Services industry, the median Owner Earnings per Share (TTM) is 17.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raia Drogasil's current Owner Earnings per Share (TTM) is 0.66, which is 99% below median its own 10-year median of 65.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$27.32, compared to a current price of R$17.53 — trading 35.8% below its estimated fair value. The current Owner Earnings per Share (TTM) is 0.66, which is 99% below median its 10-year median of 65.44 and 96.3% below the Healthcare Providers & Services industry median of 17.91. Raia Drogasil's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Owner Earnings per Share (TTM) is 0.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$17.53 is trading 35.8% below its estimated GF Value™ of R$27.32. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Owner Earnings per Share (TTM): 0.66 (99% below median its 10-year median of 65.44)
  • GF Value™: R$27.32 vs. price of R$17.53 (35.8% below fair value)
  • GF Score™: 90/100 with 2 warning signs
  • Industry Position: 96.3% below the Healthcare Providers & Services median (#197 of 300)

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
90GF Score

Get the complete analysis for BSP:RADL3

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$17.53
Price
R$27.32
GF Value